NNOX logo

NANO-X IMAGING LTD

NNOXNASDAQ
πŸ† #4558 by market capEarnings Nov 19US Equity
$0.32β–² $0.00 (+0.34%)
Pre-market Β· at close
πŸ””
Track NNOX
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.3%
7dβ–Ό 16.2%
14dβ–Ό 34.4%
30dβ–Ό 51.3%
ytdβ–Ό 88.5%
1yβ–Ό 91.4%
🏦Market Cap
$25M
Small Cap
πŸ“ˆRevenue Growth (YoY)
72.3%
High Growth
πŸ“ŠGross Margin
-77.2%
Thin
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
1.6x
Cheap
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$0.32 – $0.33
52-Week Range
$0.32 – $4.71
Volume (shares)
7,985
Avg Volume (shares)
β€”
Shares Outstanding
78.6M
Next Earnings
2026-11-19

Fundamentals Snapshot

Annual Revenue
$13M
Last Q Revenue
$4M
P/E Ratio
β€”
P/S Ratio
1.6x
EPS (TTM)
$-1.71
Dividend Yield
β€”
Dilution (1yr)
+11.5%
NNOX logo

NANO-X IMAGING LTD

NNOX
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$13Mβ–² +15.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-98.2%β–² +4.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$61Mβ–² +7.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$45Mβ–² +14.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
67.1Mβ–² +11.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$41Mβ–² +$9M YoY
StockOtter Β· stockotter.space

About NANO-X IMAGING LTD

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Buy
9 analysts
Strong Buy3
Buy4
Hold2
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.